Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)Dec 14 (Reuters) - European shares rose on Monday, as a decision to extend trade talks between Britain and the European Union kept hopes of...
14 Dec 20 08:13LONDON BRIEFING: Pound Jumps As UK And EU Agree To Continue To Talk
14 Dec 20 08:05(Sharecast News) - AstraZeneca announced on Monday that 'Trixeo Aerosphere', or formoterol fumarate, glycopyrronium bromide and budesonide, has received approval in the European Union (EU).
14 Dec 20 07:38(Sharecast News) - Pharmaceutical company AstraZeneca said it was buying US drug developer Alexion in a cash and shares deal worth $39bn.
14 Dec 20 07:01(Repeats Friday's story with no changes to the text)* India ready for vaccines needing 2 to 8 degrees Celsius storage* AstraZeneca, Bharat Biotech, RDIF's Sputnik V among frontrunners* Pfizer, Moderna unlikely to be able to supply India with volum...
13 Dec 20 23:30(Sharecast News) - Britain and the EU have taken a step forward towards striking a post-Brexit trade and security deal after Boris Johnson and Ursula von der Leyen agreed to "go the extra mile" and ordered the resumption of talks in Brussels. The prime minister played down expectations following the telephone conversation with the European commission president, telling the cabinet to prepare for a no-deal exit when the transition period ends in three weeks' time. But in Brussels, EU embassies were briefed by the commission that "progress has been made" and that "the next days will be important". - Guardian
13 Dec 20 18:57(Adds details, Slaoui quotes, background)WASHINGTON, Dec 13 (Reuters) - The United States expects to have immunized 100 million people with the coronavirus vaccine by the end of March, the chief adviser for the U.S. COVID-19 vaccine program said o...
13 Dec 20 15:46TOP NEWS: AstraZeneca Buys US Biotech Firm Alexion For USD39 Billion
12 Dec 20 15:05(Adds detail, background)Dec 12 (Reuters) - Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.AstraZeneca, one of the frontrun...
12 Dec 20 13:33(Updates with more details of transaction.)Dec 12 (Reuters) - Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.AstraZeneca, o...
12 Dec 20 13:33* Astra to pay $60 in cash, 2.1243 ADS per Alexion shares* Values Alexion shares at around $175 per share* To finance equity component with capital increase (Adds AstraZeneca executive comments, background)By Rebecca Spalding and Ludwig BurgerDec 12...
12 Dec 20 13:33* Astra to pay $60 in cash, $115 in equity per Alexion share* To finance equity component with capital increase* Expects deal to immediately boost core earnings (Adds detail, background)By Ludwig BurgerFRANKFURT, Dec 12 (Reuters) - Britain's AstraZe...
12 Dec 20 13:33* Astra to pay $60 in cash, $115 in equity per Alexion share* To finance equity component with capital increase* Expects deal to immediately boost core earnings (Adds details on cash call, CEO, drugs acquired)By Ludwig BurgerFRANKFURT, Dec 12 (Reute...
12 Dec 20 13:33* AstraZeneca to pay $60 in cash, $115 in equity per Alexion share* To finance equity component with capital increase* Expects deal to immediately boost core earnings (Adds details)By Ludwig BurgerFRANKFURT, Dec 12 (Reuters) - Britain's AstraZeneca...
12 Dec 20 13:33(Repeats without changes to text)Dec 12 (Reuters) - Astrazeneca Plc will acquire U.S. based Alexion Pharmaceuticals in a $39 billion deal, the company said in a statement on Saturday.Alexion shareholders will receive $60 in cash and 2.1243 AstraZe...
12 Dec 20 13:24
Last checked at